World
Politics
Business
Investing

Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Pinterest Email

previous post

5 Biggest Blockchain ETFs in 2025

next post

UAE AMBASSADOR YOUSEF AL OTAIBA: US and UAE forge groundbreaking high-tech partnership based on AI

Related Posts

Scoping Study Demonstrates Low Cost ISR Uranium Potential

June 5, 2025

Wildfires Slash Canadian Oil Output by 7 Percent

June 5, 2025

Victoria Gold-Silver Exploration Update

June 5, 2025

Finlay Minerals Announces Increase in Size of Non-Brokered Private Placement...

June 5, 2025

Satellite Imagery and Gold Exploration

June 5, 2025

Premier American Uranium to Acquire Nuclear Fuels, Creating One of...

June 5, 2025

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent

Top Salvadoran ex-military officers sentenced for wartime killing of Dutch journalists

June 5, 2025
‘Death and hunger’: Videos, expert analysis and witnesses point to Israeli gunfire in Gaza aid site shooting

June 5, 2025
Argentina’s president denies new intelligence plan could enable surveillance of journalists and politicians

June 5, 2025
US vetoes UN Security Council resolution demanding Gaza ceasefire

June 5, 2025
Germany’s straight-talking new leader is meeting with Trump for the first time. Here’s why it matters

June 5, 2025

Categories

Business (1,391)
Investing (3,389)
Politics (4,536)
World (4,451)

Email Whitelisting
Terms and Conditions
Privacy Policy
Contacts
About us

Disclaimer: EconomicRulesHub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 EconomicRulesHub.com | All Rights Reserved

World
Politics
Business
Investing